IDEXX Laboratories
Stock Forecast, Prediction & Price Target
IDEXX Laboratories Financial Estimates
IDEXX Laboratories Revenue Estimates
IDEXX Laboratories EBITDA Estimates
IDEXX Laboratories Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $3.21B N/A | $3.36B 4.72% | $3.66B 8.71% | Avg: $4.33B Low: $4.25B High: $4.40B avg. 18.51% | Avg: $4.77B Low: $4.71B High: $4.82B avg. 10.10% | Avg: $5.26B Low: $5.19B High: $5.31B avg. 10.11% | Avg: $5.79B Low: $5.72B High: $5.85B avg. 10.14% |
Net Income
% change YoY
| $744.84M N/A | $679.08M -8.82% | $845.04M 24.43% | Avg: $1.03B Low: $984.22M High: $1.10B avg. 22.56% | Avg: $1.16B Low: $1.08B High: $1.26B avg. 12.66% | Avg: $1.38B Low: $1.36B High: $1.40B avg. 18.69% | Avg: $1.59B Low: $1.56B High: $1.61B avg. 15.13% |
EBITDA
% change YoY
| $932.02M N/A | $898.76M -3.56% | $1.21B 35.48% | Avg: $1.16B Low: $1.14B High: $1.18B avg. -4.31% | Avg: $1.28B Low: $1.26B High: $1.29B avg. 10.10% | Avg: $1.41B Low: $1.39B High: $1.42B avg. 10.11% | Avg: $1.55B Low: $1.53B High: $1.57B avg. 10.14% |
EPS
% change YoY
| $8.74 N/A | $8.12 -7.09% | $10.17 25.24% | Avg: $12.51 Low: $11.72 High: $13.17 avg. 23.05% | Avg: $14.31 Low: $12.96 High: $15.1 avg. 14.37% | Avg: $16.49 Low: $16.23 High: $16.72 avg. 15.22% | Avg: $18.99 Low: $18.69 High: $19.25 avg. 15.13% |
Operating Expenses
% change YoY
| $957.40M N/A | $1.10B 15.47% | $1.09B -1.15% | Avg: $1.12B Low: $1.10B High: $1.14B avg. 3.27% | Avg: $1.24B Low: $1.22B High: $1.25B avg. 10.10% | Avg: $1.36B Low: $1.35B High: $1.38B avg. 10.11% | Avg: $1.50B Low: $1.48B High: $1.52B avg. 10.14% |
FAQ
What is IDEXX Laboratories stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 17.26% in 2025-2028.
We have gathered data from 8 analysts. Their low estimate is 984.22M, average is 1.03B and high is 1.10B.
What is IDEXX Laboratories stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 12.21% in 2025-2028.
We have gathered data from 9 analysts. Their low revenue estimate is $4.25B, average is $4.33B and high is $4.40B.
What is IDEXX Laboratories stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 16.94% in 2025-2028.
We have gathered data from 8 analysts. Their low earnings per share estimate is $11.72, average is $12.51 and high is $13.17.
What is the best performing analyst?
In the last twelve months analysts have been covering IDEXX Laboratories stock. The most successful analyst is Jonathan Block.